Table 2 Clinicopathological characteristics of the WEA cohort.
From: Circulating microRNA-197-3p as a potential biomarker for asbestos exposure
Diseases, not related to asbestos | Yes/no | N (%) |
---|---|---|
Musculoskeletal diseases (yes/no) | Yes | 7 (9.3) |
No | 57 (76.0) | |
N/A | 11 (14.7)* | |
Cardiovascular diseases (yes/no) | Yes | 29 (38.7) |
No | 35 (46.7) | |
N/A | 11 (14.7) * | |
Gastrointestinal diseases (yes/no) | Yes | 10 (13.3) |
No | 54 (72.0) | |
N/A | 11 (14.7) * | |
Endocrine diseases (yes/no) | Yes | 20 (26.7) |
No | 44 (58.7) | |
N/A | 11 (14.7) * | |
Respiratory diseases (yes/no) | Yes | 15 (20.0) |
No | 49 (65.3) | |
N/A | 11 (14.7) * | |
Neurological diseases (yes/no) | Yes | 5 (6.7) |
No | 59 (78.7) | |
N/A | 11 (14.7)* | |
Genitourinary diseases (yes/no) | Yes | 11 (14.7) |
No | 53 (70.7) | |
N/A | 11 (14.7)* | |
Neoplastic diseases (yes/no) | Yes | 10 (13.3) |
No | 54 (72.0) | |
N/A | 11 (14.7)* | |
Therapy (yes/no) | Yes | 57 (76.0) |
No | 18 (24.0) | |
N/A | 0 |